Ribozymes in Cancer Gene Therapy

This publication has 131 references indexed in Scilit:

• The 5′-End of hTERT mRNA Is a Good Target for Hammerhead Ribozyme to Suppress Telomerase Activity
  Biochemical and Biophysical Research Communications, 2000
• Repression of Hepatitis B Virus X Gene Expression by Hammerhead Ribozymes
  Biochemical and Biophysical Research Communications, 1999
• Hammerhead Ribozyme Specifically Inhibits Mutant K-ras mRNA of Human Pancreatic Cancer Cells
  Biochemical and Biophysical Research Communications, 1998
• Reduction of Cripto-1 Expression by a Hammerhead-Shaped RNA Molecule Results from Inhibition of Translation Rather Than mRNA Cleavage
  Biochemical and Biophysical Research Communications, 1998
• Ex VivoEffects Associated with the Expression of abcr-abl-Speciftc Ribozyme in a CML Cell Line
  Antisense and Nucleic Acid Drug Development, 1998
• Hammerhead Ribozyme-Mediated Inhibition of Telomerase Activity in Extracts of Human Hepatocellular Carcinoma Cells
  Biochemical and Biophysical Research Communications, 1996
• Kinetic Selectivity of Complementary Nucleic Acids:bcr-abl-directed Antisense RNA and Ribozymes
  Journal of Molecular Biology, 1996
• Designing of chimeric DNA/RNA hammerhead ribozymes to be targeted againstAML1/MTG8 mRNA
  Zeitschrift für Krebsforschung und Klinische Onkologie, 1996
• Ribozymes Cleave the AML1/MTG8 Fusion Transcript and Inhibit Proliferation of Leukemic Cells with t (8;21)
  Biochemical and Biophysical Research Communications, 1995
• Cleavage of hepatitis B virus RNA by three ribozymes transcribed from a single DNA template
  Biochemical and Biophysical Research Communications, 1992